Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Restricted Stock (Details)

v3.22.2
Stockholders' Equity - Restricted Stock (Details) - Unvested restricted stock
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares, Nonvested beginning balance | shares 4,512,701
Number of shares, Granted | shares 1,529,214
Number of Shares, Forfeited | shares (84,000)
Number of shares, Vested | shares (2,074,710)
Number of shares, Nonvested ending balance | shares 3,883,205
Weighted Average Exercise Price, Nonvested beginning balance | $ / shares $ 3.35
Weighted Average Grant Date Fair Value, Granted | $ / shares 2.04
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 2.75
Weighted Average Grant Date Fair Value, Vested | $ / shares 3.68
Weighted Average Exercise Price, Nonvested ending balance | $ / shares $ 2.67